Eleonora Lugarà

Sr Translational Research Manager @UCLIoN/@UCLTRO.
Previous scientist at @UCB working on #epilepsy, #GeneTheraphy and small molecules. MarieCurie| IIT Alumni.

[AlbionVC @AlbionVC]

Spark Time with @goldie_oz , partner @AlbionVC. Simon shares with #MightySparkCommunications his perspectives on translating #science out of academia and into the clinic, as well as what selling means in the US versus the UK. Listen more here: https://t.co/J0ua82Y4pF
@UCLTF

[Eleonora Lugarà @Eleonorawho]

"precision approaches such as base and prime editing got relatively little attention this year compared to epigenetic modulation and novel targeting approaches", very insightful piece by @goldie_oz ! #ASGCT2024 #investments #biotech #Innovation

[Simon Goldman @goldie_oz]

Lots of shiny new #advancedtx platforms were on show at #ASGCT2024 but the commercial reality of gaining widespread adoption is sinking in —> 2-min read from @Tanelography and I @AlbionVC wrapping up a busy week in Baltimore https://t.co/N3ksSJRgn3

[Brad Loncar @bradloncar]

Credit to @skathire for speaking about this today. Not all companies do.

[Orchard Therapeutics - U.S. @orchard_tx]

We are thrilled to announce that the @US_FDA has approved Lenmeldy™ (atidarsagene autotemcel), the only therapy for eligible children with early-onset metachromatic leukodystrophy in the U.S. Read more in our press release: https://t.co/loHlBb22V7.

[Simon Goldman @goldie_oz]

When you're alone in a (scientific/modality/indication) field, are you mad or are you a genius? Tough balance to strike in #biotechVC. Lots of other people in the sandpit provides validation but also competition. For me, unmet need & reimbursement/revenue opp shld drive decisions

[Helen Branswell 🇨🇦 @HelenBranswell]

The #ALS community got devastating news today with the revelation that a Phase 3 trial showed the approved drug Relyvrio doesn't work. My colleagues @adamfeuerstein & @damiangarde have a must-read on what the news means. 🔒 https://t.co/rI3R9RXSdJ

[Angelini Pharma @AngeliniPharma]

Earlier this month, we launched an Open Innovation Challenge, focused on digital approaches for the identification of drug targets in epilepsy, building on existing bioinformatics and artificial technologies

https://t.co/ws5igtubBX

#AngeliniPharma #EveryStepCloser

[Eleonora Lugarà @Eleonorawho]

Thank you Amy Li for inviting me to give a lecture for the course "Medical Innovation & Enterprise BSc" at UCL about translational research strategies in and outside academia. Looking forward to collaborative projects in the future! #innovation #grants #VC #duediligence

[Eleonora Lugarà @Eleonorawho]

Now happening at @UCLIoN the Multiple System Atrophy Symposium, organised by @VioricaChelban and sponsored by @ionispharma and @ThevaranceBiopharma with the support of the @MSAtrust. Fantastic lineup of speakers! Let's end MSA together. #MSA #genetics #translation

[Eleonora Lugarà @Eleonorawho]

Congratulations 🎉 Professor @gabrilignani !!!

[UCL Brain Sciences @UCLBrainScience]

Six UCL researchers, including Prof Gabriele Lignani @gabrilignani (@UCLIoN), have received EU funding to support their work for the next five years in a range of fields including economics, neuroscience and archaeology.

Read more ⬇️ https://t.co/AEBOihODBD

[Eleonora Lugarà @Eleonorawho]

Congratulations 🎉 @gabrilignani !!!

[UCL Brain Sciences @UCLBrainScience]

Six UCL researchers, including Prof Gabriele Lignani @gabrilignani (@UCLIoN), have received EU funding to support their work for the next five years in a range of fields including economics, neuroscience and archaeology.

Read more ⬇️ https://t.co/AEBOihODBD

[UCL Brain Sciences @UCLBrainScience]

Prof Ed Wild (@UCLIoN) will be joining journalist Charles Sabine at the @TEDx Bath event to talk about transforming approaches to degenerative brain diseases like Huntington’s, and developments that have been made.

🗓️ 14 Oct, 1.30pm

More details ⬇️
https://t.co/8a4CPvbgT6

[UCL Brain Sciences @UCLBrainScience]

📸 Prof Alan Thompson with Mr Haruo Naito, CEO of Eisai, and UCL President & Provost Dr Michael Spence in Japan.

UCL scientists and Eisai have been working together to develop solutions for patients with neurodegenerative conditions ➡️ https://t.co/qrNG9fUEJM

#UCLandJapan

[The Neurogenetics Lab UCL ION @IonSynapse]

During their recent trip to Iraq, Prof Henry Houlden & Dr @EhsanKarimiani met with patients and also local clinicians to discuss ongoing collaborations into genetic research on neurological disorders. @UCL_Global @UCLIoN @UCLBrainScience

[Francesca Magrinelli @FraMagrinelli]

📢 SAVE THE DATE 📢 Next Basal Ganglia Club Meeting - November 22, 2023 - 4 pm - Gilliatt Lecture Theatre, Queen Square - Speakers @BandmannOliver & @chtzoulis - All welcome - Please RT @UCLIoN @MDC_IoN_UCL @neurolib @kailashbhatia

[Pedro Machado @pedrommcmachado]

Thank you @TheLancetNeuro for recognising the value of this article! An excellent example of collaboration between industry and academia, and one of the largest IBM trials to date, providing important lessons for IBM research @MikeHanna18 @UCLIoN @UCL_QS_CNMD

[Bio-protocol @bioprotocolbyte]

Neonatal mice intraperitoneal injection: Safe, rapid, precise dosing for early treatments and research. 🌟
Read👉https://t.co/rCB3QSEKIP by Amanda Pocratsky and @J_N_Slayer at @UCLIoN

#MouseResearch #PreclinicalTherapeutics #bioprotocol #OpenAccess

[The Neurogenetics Lab UCL ION @IonSynapse]

We invite you to join us at our second MSA Symposium @UCLIoN on 9th Feb 2024. After the success of our inaugural symposium last year, we are thrilled to announce an exceptional line-up of speakers!
Click on link below to learn more & register. @MSAtrust
https://t.co/mJGH5JaGIL

[UCL Brain Sciences @UCLBrainScience]

Prof @alexander_leff (@UCLIoN) discusses the Gotcha! App, designed to help people with #dementia get lots of practice in order to retrieve the names of people who are important to them.

Read more ➡️ https://t.co/uw32rMcGjE

#UCLDementia #WorldAlzheimersMonth

[LifeArc @lifearc1]

A new report details how £1.1 billion was invested by the Government and charities in rare diseases.➡️ https://t.co/hhvyxAOWAN

We’re proud to play a part in funding rare disease research, ultimately helping bring benefits to patients. @NIHRresearch @The_MRC